Facilitating Advance Care Planning Discussions for People With Advanced Cancer
Completed · Not applicable
Conditions studied: Resilience, Psychological, Advance Care Planning
In brief
The aims of this study are to (1) identify the advance care planning deliberation process among 20 dyads of patients with advanced cancer and family caregivers and (2) conduct usability testing among 9 dyads to refine the content and design of the web-based resilience-building intervention.
Key facts
- Study ID
- NCT06061965
- Run by
- University of Illinois at Chicago
- People needed
- 36
- Starts
- 2024-07-09
- Expected to finish
- 2025-05-22
- Last updated by the study team
- 2026-01-29
Who can join
Age: 18 and older, up to 80. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- Patients will be eligible for the study if they (1) are ≥ 18 years of age; (2) have a cancer diagnosis; (3) are able to read and respond to questions in English with minimal assistance from family caregivers for interpretation; (4) have previously completed an advance directive such as a living will; (5) have a family caregiver who serves as a surrogate in the advance directive and is willing to participate in the study; and (6) have access to the internet on a cell phone, laptop, or computer.
- Family caregivers will be eligible if they (1) are ≥ 18 years of age; (2) are able to read and respond to questions in English with minimal assistance from others for interpretation; (3) are identified by the patient as a family caregiver who serves as a surrogate for health care decisions; and (4) have access to the internet on a cell phone, laptop, or computer.
You may not qualify if…
- Patients who have cognitive impairment per a Short Portable Mental Status Questionnaire score < 8.
Where it is running
- University of Illinois Chicago — Chicago, Illinois, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.